is not useful prognostically-as the predominant form of heart failure (HF) (1) . In this contemporary review, LVEF and strain are compared to evaluate the benefits of combining these complementary techniques. Despite initial hopes that this method would improve the quantification of regional function, this application has been disappointing.
MARKERS OF GLOBAL LV SYSTOLIC FUNCTION
In contrast, the derivation of global longitudinal strain (GLS) from averaging multiple regions has overcome the effects of regional noise and provided a remarkably robust systolic function marker. Detailed practical and technical guidance relating to strain measurement has been published (6, 7) . For the purposes of this review, "strain" refers to Lagrangian strain by speckle-tracking echocardiography, which has superseded Doppler-based measurement (natural strain).
In the interest of simplicity, GLS values The early phases of the development of strain were marked by significant intervendor variability, and vendor-independent software was used to circumvent this problem (13) . Since the publication of the consensus paper from the European Association of Cardiovascular Imaging (EACVI)/American Society of Echocardiography (ASE) Industry Task Force (14), intervendor differences in strain measurements have been markedly reduced to levels similar to (or less than) those of standard parameters, including LVEF (15, 16) .
REFERENCE RANGES.
Although the normal range of LVEF is >53%, the most prognostic value is present when EF is <40%, with very little prognostic information provided in the mild or borderline ranges ( Figure 2) . Normal reference ranges for GLS have been determined by meta-analysis of study control groups and healthy volunteers (17) . In 24 studies involving 2,597 subjects, normal values ranged from 15.9% to 22.1% (mean 19.7%; 95% CI: 20.4 to 18.9%). Metaregression for sources of interstudy variability in strain values found systolic blood pressure to be a significant contributor. Strain declines with age (without a significant drop in LVEF) (18) , but sex has a more significant impact on normal strain values. In the general population (without cardiovascular disease or traditional risk factors), the absolute GLS difference between men and women is >1% (19, 20) .
CLINICAL VALUE FROM FUNCTIONAL EVALUATION WITH STRAIN
RISK PREDICTION. Reductions in LVEF portend worse cardiovascular outcomes (21) (22) (23) (24) . Although there is an inverse relationship between LVEF and allcause mortality rate, this plateaus at an EF of 40% to 45%, above which EF is unrelated to mortality ( Figure 2 ) (24). Despite this finding, patients with HF have a similar 1-year mortality rate irrespective of whether they have preserved EF (HFpEF) or reduced EF (HFrEF) (25) . In contrast, GLS is a correlate of mortality, independent of and incremental to LVEF in patients with HFrEF (26) (27) (28) . In particular, GLS adds significant incremental predictive value for mortality in patients with LVEF >35% (Figure 3) . A metaanalysis of 5,721 subjects across 16 studies of various cardiac diseases confirmed that GLS is a stronger predictor than LVEF of all-cause mortality and a composite of cardiac death, HF hospitalization, and malignant arrhythmias (28) .
Strain imaging has also shown prognostic utility over traditional imaging markers of LV function after acute myocardial infarction (AMI) (29) . In 603 pa- depending on risk profiles, cumulative anthracycline dose, and therapy combinations (32, 33) . Impairments in GLS precede reductions in LVEF, with a 10% to 15% Reduced strain has been demonstrated in several populations at risk of HF ( Figure 4) , and it may be the only sign of LVD. In hypertensive subjects with normal LVEF, GLS reduction is observed independent of LV hypertrophy and diastolic dysfunction (35) , and it confers elevated cardiovascular risk (36) . Similarly, LVD has been reported in more than one-half of asymptomatic subjects with diabetes mellitus (DM) (37, 38) . In the absence of ischemic heart disease (IHD) and hypertension, this entity has been termed diabetic cardiomyopathy (39) , and its phenotype is commonly considered one of early diastolic dysfunction. Diastolic dysfunction in this setting has prognostic significance but may be attributable to hypertension and obesity (40, 41) . Approximately one-third of asymptomatic DM is associated with abnormal GLS with normal diastolic function (and LVEF) (42), and GLS may be a signal that is more specific for diabetic cardiomyopathy than are diastolic changes. GLS improves the sensitivity of echocardiography in detection of early diabetic heart disease. Furthermore, strain-defined LVD is predictive of worse outcomes in DM with normal LVEF (without HF symptoms or IHD) and appears superior in this regard to diastolic dysfunction (assessed by E/e 0 ) (37, 43) , although some data are conflicting (44) .
The variation in the relative prognostic roles of GLS and diastolic dysfunction likely relates to the predominant underlying pathophysiology of myocardial disease in DM and hypertension.
Obesity-induced myocardial damage occurs independent of DM, hypertension, and coronary artery disease (CAD), and it shares common pathophysiological mechanisms with diabetic heart disease (45).
Overweight is associated with reductions in strain in a "dose-dependent" manner and independent of associated elevations in blood pressure, LV mass, and circulating insulin (46) . HYPERTROPHY. In patients with nonobstructive hypertrophic cardiomyopathy (HCM), imaging provides information on the differential diagnosis, as well as prognosis (65) . Overt LVD is uncommon, but it heralds a dire prognosis. Reduction of GLS to 15% in an HCM patient cohort with normal LVEF was associated with fibrosis (66, 67) . Reduced GLS is the strongest independent predictor of fibrosis assessed by late gadolinium enhancement on cardiac magnetic resonance imaging; in the presence of late gadolinium enhancement, GLS was 11.8 AE 2.8%, compared with 15 AE 1.7% in its absence (68) . Furthermore, reduced GLS has prognostic significance in HCM with preserved LVEF (68-70) ; GLS was the strongest independent predictor of outcome (ventricular arrhythmia, HF, transplantation, and all-cause death) in a recent study of 400 subjects with HCM who were followed for >3 years (69) . GLS <10% portended 4 times the risk compared with GLS >16%, and there was significantly worse event-free survival when subjects were dichotomized by a GLS cutoff of Lesion-specific regional circumferential strain is able to identify coronary occlusion within an hour of presentation with high sensitivity and specificity (79) .
Following AMI, GLS may improve risk prediction for all-cause mortality and cardiovascular composite endpoints when LVEF is in the intermediate range (80) . Reduced GLS can predict infarct size; a GLS <15% independently predicts infarct mass $30 g with sensitivity and specificity of 83% and 93%, respectively (81).
CENTRAL ILLUSTRATION Prognostic and Management Implications of Abnormal Strain Measurement in Common
Clinical Scenarios The recognition of clinically significant abnormal values is more difficult because the parameter is influenced by age, sex, and loading conditions, not only afterload but also preload (82) . Indeed, abnormal GLS has been variably defined on the basis of underlying pathology and outcomes ( Table 1) . In proposing a GLS cutoff, it would be prudent to select a lower threshold than the normal reference range to maximize specificity for adverse outcomes across common disease or at-risk groups. A sex influence appears consistent in healthy populations, but the impact on outcomes in disease states is not well established. In addition, sex-and age-based reference ranges quoted in some data have large CIs (19) ( Table 1) .
TECHNICAL CONSIDERATIONS. The feasibility of GLS has been improved by the wide availability of post-processing algorithms. However, as with the adoption of all new technologies, inertia needs to be overcome by education and training. Although the learning curve for an echocardiographer to obtain appropriate images is small, it warrants a process of validation and audit (12) . User education is needed for general physicians and general practitioners, who typically share the care of multimorbid and community-based patients with stage B HF and HFpEF; strain has much to offer for these patients.
The previous variability in measurements among various manufacturers was a significant barrier to the adoption of this method because it prevented adoption of a standardized normal range, and it meant that the use of different echocardiography machines from one visit to the next provided (or obscured) differences. Although the use of the same manufacturer is advisable from visit to visit, this cause of variability has been substantially reduced since the conclusion of a concordance process (16) . Although LVEF will remain a cornerstone of LV function assessment, the addition of GLS enables detailed phenotyping and improved risk assessment and is a tool for present and future therapeutic advancement.
